Varian’s IDE win makes way for first ever FLASH therapy clinical trial

By Nikita Chaurasia  | Date: 2020-10-13

Varian’s IDE win makes way for first ever FLASH therapy clinical trial

U.S.-based radiotherapy technology company, Varian Medical Systems has made it to the headlines for reportedly receiving an IDE (Investigational Device Exemption) from the U.S. Food & Drug Administration.

For the uninitiated, FLASH therapy is an innovative radiation treatment that involves ultra-high dose rates of radiotherapy. The study, named FAST-01, will conduct the investigation using Varian's ProBeam particle accelerator which is apparently modified with a specialized module with FLASH capabilities.

If reports are to be believed, the trial will involve over 10 patients with bone metastases and evaluate parameters such as side-effects, efficacy of the treatment and clinical workflow feasibility. In fact, preclinical trials conducted by Varian suggested that the new technology is significantly faster and causes lesser tissue damage as compared to conventional radiotherapy.

It is to be noted that Varian has supported the FlashForward Cosortium, a 20-member group of institutions from across the globe, that includes experts in translational sciences, radiation oncology and medical physics.

Speaking of the trials, President of Proton Therapy Solutions and Chief Growth Officer at Varian, Kolleen Kennedy, was reported saying that the company’s advancement in FLASH therapy is a testament to their investments and efforts towards improving cancer treatment.

Dr. Deepak Khuntia, Chief Medical Officer and Senior VP of Varian mentioned in a comment that the investigation is vital proof of concept, particularly in deep-seated as well as superficial tumors. It will impart a thorough understanding regarding the operations of FLASH therapy , he added.

Sources close to the matter claim that the patient enrollment in the FAST-01 Feasibility Study is expected to commence by the end of the year 2020.

About Varian Medical Systems

California-headquartered Varian Medical Systems is a radiation oncology treatments and software company and focuses on developing innovative cancer care technologies and solutions.

With over 10,000 employees across 70 locations, the company harnesses advanced technologies such as machine learning, AI (artificial intelligence) and data analytics in order to enhance cancer treatment.

 

Source credits: https://www.prnewswire.com/news-releases/varian-receives-investigational-device-exemption-ide-and-prepares-for-first-ever-clinical-trial-of-flash-therapy-301149339.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

WeWork India rectifies glitch that revealed visitors’ personal data

WeWork India rectifies glitch that revealed visitors’ personal data

By Nikita Chaurasia

WeWork Inc., a flexible workspace solutions company, has reportedly corrected a security flaw that gave unrestrained access to the personal details and selfies of several users who visited its coworking spaces. Sandeep Hodkasia, a security consult...

China’s Great Wall Motor suspends USD 1 Bn investment plan in India

China’s Great Wall Motor suspends USD 1 Bn investment plan in India

By Nikita Chaurasia

After failing to get regulatory permits, China's Great Wall Motor has reportedly abandoned its plans to invest USD 1 billion in India and has fired all employees from its Indian facilities. The Chinese automaker had planned to penetrate the India...

Walmart to double down on frictionless optical care with Memomi buyout

Walmart to double down on frictionless optical care with Memomi buyout

By Nikita Chaurasia

Walmart Inc. is reportedly planning to acquire the augmented reality optical tech firm Memomi, reflecting the retailer’s commitment to offering frictionless and omnichannel optical care. The buyout could potentially allow Walmart to offer a fun...

Google faces antitrust lawsuit from Danish job search entity Jobindex

Google faces antitrust lawsuit from Danish job search entity Jobindex

By Nikita Chaurasia

Google LLC was reportedly hit with an antitrust case by Jobindex, a Danish online job-search rival, that took its grievance to European regulators asserting that Alphabet Inc.’s subsidiary is unjustly favoring its job-search engine. The comp...

EU vows USD 630 Mn aid to vulnerable countries amidst Ukraine-conflict

EU vows USD 630 Mn aid to vulnerable countries amidst Ukraine-conflict

By Nikita Chaurasia

The European Union has reportedly pledged USD 630 million to support weaker nations to tackle food scarcity that was made worse by Russia's assault on Ukraine. The funds include USD 368 million in aid to increase long-term sustainable food produc...